Skip to content

US · RDGT · MEDICAL - DISTRIBUTION

Ridgetech, Inc. (RDGT) intrinsic value and stock valuation

$0.94as of 2026-11-21 · Mkt cap 670.41K

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Ridgetech, Inc. DCF and intrinsic value

InvestorsCraft values RDGT with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from RDGT’s statements →

Ridgetech, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Distribution Hangzhou, ZH 310008 ridgetch.com

How the business is doing

Fiscal 2012–2026, USD

Revenue
$132.2M-0.1% 5y CAGRd
20122026
Net income
-$-1.25M
20122026
Free cash flow
-$-1.39M
20122026
Total equity
$40.8M+10.8% 5y CAGRd
20122026

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2012–2026, USD
20262025202420232022
Revenue$132.2M$120M$154.5M$148.8M$164.4M
Operating income-$-1.87M-$-1.04M-$-3.53M-$-20.93M-$-2.69M
Net income-$-1.25M$10.2M-$-4.23M-$-21.14M-$-3.19M
EPSd-$-17.86M————
Operating cash flow-$-1.39M$1.25M-$-3.16M-$-3.28M-$-5.39M
Capital expenditure-$0.00-$-620K-$-920K-$-310K-$-310K
Free cash flow-$-1.39M$630K-$-4.08M-$-3.6M-$-5.69M
Total assets$69M$64.5M$95.1M$91M$106.4M
Total debt$20K$10.4M$43.2M$42.2M$48.7M
Net debt-$-17.89M-$-2.39M$23.1M$23.4M$30.2M
Total equity$40.8M$29.6M$14.3M$16.7M$22.7M
Cash and short-term investments$17.9M$12.8M$20.2M$18.8M$18.5M
Income statement
20262025202420232022
Revenue$132.2M$120M$154.5M$148.8M$164.4M
Cost of revenue$127.4M$116.1M$123.4M$114.5M$127.9M
Gross profit$4.75M$3.84M$31.1M$34.3M$36.5M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$6.62M$4.87M$34.6M$55.2M$39.1M
Other expenses$0.00$0.00$0.00$0.00$150K
Operating expenses$6.62M$4.87M$34.6M$55.2M$39.2M
Cost and expenses$134M$121M$158.1M$169.7M$167.1M
Interest income$460K$90K$520K$880K$400K
Interest expense$70K$0.00$10K$70K$260K
Depreciation and amortization$360K$6.02M$5.38M$720K$1.26M
Ebitda-$-1.5M$4.98M$1.23M-$-19.96M-$-580K
Operating income-$-1.87M-$-1.04M-$-3.53M-$-20.93M-$-2.69M
Total other income/expenses, net$520K$80K-$-640K$180K$600K
Income before tax-$-1.35M-$-950K-$-4.17M-$-20.74M-$-2.1M
Income tax expense-$-100K$500K$60K$390K$1.1M
Net income-$-1.25M$10.2M-$-4.23M-$-21.14M-$-3.19M
Weighted average shares outstanding$70K$0.00$0.00$0.00$0.00
Weighted average diluted shares outstanding$70K$0.00$0.00$0.00$0.00
Balance sheet
20262025202420232022
Cash and short-term investments$17.9M$12.8M$20.2M$18.8M$18.5M
Net receivables$38M$30.2M$19.1M$16.8M$22.5M
Inventory$8.36M$9.76M$16.3M$15.3M$16M
Total current assets$64.6M$59.7M$69.7M$64.5M$75.4M
Property, plant and equipment, net$10K$10K$18.7M$19M$19.7M
Goodwill and intangible assets$4.47M$4.77M$3.65M$3.89M$4.37M
Long-term investments$0.00$0.00$1.2M$1.77M$4.51M
Total non-current assets$4.47M$4.78M$25.4M$26.5M$31M
Total assets$69M$64.5M$95.1M$91M$106.4M
Accounts payable$22.8M$19.7M$31.6M$27M$27.3M
Short-term debt$20K$10.4M$36.8M$34.4M$39.5M
Deferred revenue$0.00$260K$520K$700K$1.87M
Total current liabilities$27.9M$34.4M$74.4M$66.5M$74.5M
Long-term debt$0.00$0.00$6.4M$7.77M$9.2M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$360K$490K$6.4M$7.77M$9.2M
Capital lease obligations$0.00$0.00$11.3M$12.9M$12.5M
Total liabilities$28.3M$34.9M$80.8M$74.3M$83.7M
Common stock$130K$1.41M$420K$280K$40K
Retained earnings-$-64.56M-$-63.31M-$-73.51M-$-69.27M-$-48.13M
Accumulated other comprehensive income (loss)$1.31M-$-200K$2.31M$3.04M$5.66M
Total equity$40.8M$29.6M$14.3M$16.7M$22.7M
Total investments$0.00$0.00$1.2M$1.77M$4.51M
Total debt$20K$10.4M$43.2M$42.2M$48.7M
Net debt-$-17.89M-$-2.39M$23.1M$23.4M$30.2M
Cash flow statement
20262025202420232022
Net income-$-1.25M$10.2M-$-4.23M-$-21.14M-$-3.2M
Depreciation and amortization$360K$6.02M$5.38M$720K$1.26M
Stock-based compensation$0.00$0.00$0.00$10.4M$0.00
Change in working capital$0.00$730K-$-5.77M-$-3.12M-$-4.53M
Accounts receivable-$-5.47M-$-1.75M-$-2.78M-$-3.51M-$-4.54M
Inventory$2.4M$410K-$-1.7M-$-520K$1.52M
Accounts payable$2.01M-$-21.13M$6M$1.77M-$-3.56M
Net cash provided by operating activities-$-1.39M$1.25M-$-3.16M-$-3.28M-$-5.39M
Investments in property, plant and equipment-$0.00-$-620K-$-860K-$-300K-$-300K
Acquisitions, net$0.00-$-17.52M-$-1.12M-$0.00$0.00
Net cash used for investing activities-$0.00-$-18.14M-$-2.04M-$-320K-$-310K
Common stock issued$10.9M$7.63M$2.59M$7.33M$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities-$-30K$1.51M$8M$2.37M$4.84M
Net change in cash-$-630K-$-14.33M$1.3M-$-3.77M$670K
Cash at end of period$17.9M$18.5M$32.9M$31.6M$35.3M
Operating cash flow-$-1.39M$1.25M-$-3.16M-$-3.28M-$-5.39M
Capital expenditure-$0.00-$-620K-$-920K-$-310K-$-310K
Free cash flow-$-1.39M$630K-$-4.08M-$-3.6M-$-5.69M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Ridgetech, Inc.

        Ridgetech, Inc. operates as a wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. It operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale. The company engages in offline and online wholesale distribution of pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products comprising consumable, seasonal, and promotional items. It also distributes other healthcare products, such as health food, cosmetics, and daily necessities. The company was formerly known as China Jo-Jo Drugstores, Inc. and changed its name to Ridgetech, Inc. in February 2024. Ridgetech, Inc. is headquartered in Hangzhou, China.

        CEO
        Ming Zhao
        Employees
        61
        Beta
        -0.19

        Explore

        Frequently asked questions

        What is the intrinsic value of Ridgetech, Inc. (RDGT)?

        InvestorsCraft does not currently publish an intrinsic value for RDGT. How the IC value is calculated.

        Is RDGT undervalued?

        InvestorsCraft does not publish an undervaluation signal for RDGT at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.